✦ LIBER ✦

Use of reperfusion therapy in patients presenting with ST elevation myocardial infarction: Findings from the TETAMI study and TETAMI registry (the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction)

✍ Scribed by Gian Franco Gensini; Marc Cohen; Frans Maritz; Enrique P. Gurfinkel; Kurt Huber; Ari Timerman; Maria Krzeminska-Pakula; Nicolas Danchin; Harvey D. White; Luc Vittori

Book ID: 119546592
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 166 KB
Volume: 41
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(03)81068-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The safety and efficacy of subcutaneous

The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): A randomized trial

✍ Marc Cohen; Gian Franco Gensini; Frans Maritz; Enrique P Gurfinkel; Kurt Huber; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Underuse of reperfusion therapy in femal

Underuse of reperfusion therapy in female patients: Insights from the TETAMI study and registry (The safety and efficacy of subcutaneous Enoxaparin versus intravenous unfractionated heparin and of myocardial infarction)

✍ Marc Cohen; Gian Franco Gensini; Frans Maritz; Enqrique P. Gurfinkel; Kurt Huber 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

The TETAMI Trial: The Safety and Efficac

The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design

✍ Marc Cohen; Frans Maritz; Gian Franco Gensini; Nicolas Danchin; Ari Timerman; Ku 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 93 KB

The safety and efficacy of subcutaneous

The safety and efficacy of subcutaneous enoxaparin vs. intravenous unfractionated heparin and tirofiban vs. placebo in the treatment of acute st-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial

✍ M Cohen; G.F Gensini; F Maritzet al 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Effect of enoxaparin versus unfractionat

Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment–Thrombolysis In Myocardial Infarction study 25 (ExTRACT–TIMI 25) trial

✍ David A. Morrow; Elliott M. Antman; Sabina A. Murphy; Jie Qin; Mikhail Ruda; Sem 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 379 KB

Enoxaparin versus unfractionated heparin

Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)

✍ Elliott M. Antman; David A. Morrow; Carolyn H. McCabe; Frank Jiang; Harvey D. Wh 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 631 KB